Status:
COMPLETED
The Efficacy of LPPRP in the Treatment of Chondromalacia Patella
Lead Sponsor:
Kayseri City Hospital
Conditions:
Chondromalacia Patellae
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Chondromalacia patella(CP) is a common cause of anterior knee pain in the population under 50 years of age. CP is characterized by softening or varying degrees of damage to the patellar cartilage. The...
Detailed Description
A randomized, prospective, controlled study included 28 patients with MRI stage 2 and above Chondromalasia Patella findings. The patients were randomized into 2 groups, group 1 (the group in which 2 d...
Eligibility Criteria
Inclusion
- Chondromalasia Patella stage 2 and above in MRI requested from patients with chronic pain around the patella, who have increased pain in at least one of the activities that carry loads while the knee is flexed (squatting, stepping, running, jumping, jumping) after physical examination and clinical evaluation
- Patients with VAS 3 and above
- Patients over 18 years of age
- Patients without any deformity in the lower extremity
Exclusion
- Coagulopathy and/or thrombocytopenia
- Cardiovascular instability or severe disease condition
- Presence of systemic infection or malignancy
- Pregnancy
- Intra-articular injection in the last 6 months
- Stage 3 and above meniscopathy in MRI
- Evidence or suspicion of rupture of the anterior cruciate ligament on MRI
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 4 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06020794
Start Date
February 1 2021
End Date
November 4 2022
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences University, Kayseri Medicine Faculty
Kayseri, Turkey (Türkiye)